DA-6034 ameliorates hepatic steatosis and inflammation in high fat diet-induced obese mice
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Nonalcoholic fatty liver disease (NAFLD) is characterized by an increase in hepatic triglyceride content and increased inflammatory macrophage infiltration through the C-C motif chemokine receptor (CCR) 5 pathway in the liver. DA-6034 (7-carboxymethyloxy-3',4',5-trimethoxy flavone), is a synthetic derivative of eupatilin that exhibits anti-inflammatory activity in inflammatory bowel disease. However, the effect of DA-6034 on the inflammatory response in NAFLD is not well elucidated. Therefore, we aimed to determine the effect of DA-6034 on hepatic steatosis and inflammation. Methods: Forty male C57BL/6J mice were divided into the following four groups: (1) regular diet (RD), (2) RD with DA-6034, (3) high fat diet (HFD), and (4) HFD with DA-6034. All mice were sacrificed 12 weeks after the start of the experiment. The effects of DA-6034 on macrophages were assessed using RAW264.7 cells.Results: DA-6034 not only reduced hepatic triglyceride levels and lipid accumulation but also macrophage infiltration and proinflammatory cytokines in HFD-fed mice. According to fluorescence-activated cell sorter analysis, DA-6034 reduced the CD8+ T cell fraction in the liver of HFD-fed mice. DA-6034 also reduced CCR5 expression and the migration of liver macrophages in HFD-fed mice and inhibited CCR2 ligand and CCR4 ligand, which stimulated the migration of macrophages.Conclusion: Overall, DA-6034 attenuates hepatic steatosis and inflammation in obesity by regulating CCR5 expression in macrophages.
Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) is characterized by an increase in hepatic triglyceride content and increased inflammatory macrophage infiltration through the C-C motif chemokine receptor (CCR) 5 pathway in the liver. DA-6034 (7-carboxymethyloxy-3',4',5-trimethoxy flavone), is a synthetic derivative of eupatilin that exhibits anti-inflammatory activity in inflammatory bowel disease. However, the effect of DA-6034 on the inflammatory response in NAFLD is not well elucidated. Therefore, we aimed to determine the effect of DA-6034 on hepatic steatosis and inflammation. Methods: Forty male C57BL/6J mice were divided into the following four groups: (1) regular diet (RD), (2) RD with DA-6034, (3) high fat diet (HFD), and (4) HFD with DA-6034. All mice were sacrificed 12 weeks after the start of the experiment. The effects of DA-6034 on macrophages were assessed using RAW264.7 cells.Results: DA-6034 not only reduced hepatic triglyceride levels and lipid accumulation but also macrophage infiltration and proinflammatory cytokines in HFD-fed mice. According to fluorescence-activated cell sorter analysis, DA-6034 reduced the CD8+ T cell fraction in the liver of HFD-fed mice. DA-6034 also reduced CCR5 expression and the migration of liver macrophages in HFD-fed mice and inhibited CCR2 ligand and CCR4 ligand, which stimulated the migration of macrophages.Conclusion: Overall, DA-6034 attenuates hepatic steatosis and inflammation in obesity by regulating CCR5 expression in macrophages.
참고문헌 (40)
- Tiniakos DG, "Nonalcoholic fatty liver disease : pathology and pathogenesis", Annu Rev Pathol, 5, pp.145~171 (2010)
- Cohen JC, "Human fatty liver disease : old questions and new insights", Science, 332, pp.1519~1523 (2011)
- Koyama Y, "Liver inflammation and fibrosis", J Clin Invest, 127, pp.55~64 (2017)
- Liu T, "NF-κB signaling in inflammation", Signal Transduct Target Ther, 2, pp.17023~ (2017)
- Baker RG, "NF-κB, inflammation, and metabolic disease", Cell Metab, 13, pp.11~22 (2011)
- Tak PP, "NF-kappaB : a key role in inflammatory diseases", J Clin Invest, 107, pp.7~11 (2001)
- Lee BC, "Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance", Biochim Biophys Acta, 1842, pp.446~462 (2014)
- Monteiro R, "Chronic inflammation in obesity and the metabolic syndrome", Mediators Inflamm, 2010, pp.289645~ (2010)
- Fei X, "Eupatilin attenuates the inflammatory response induced by intracerebral hemorrhage through the TLR4", MyD88 pathway, 2019, pp.76, 105837~
- Du L, "Eupatilin prevents H2O2-induced oxidative stress and apoptosis in human retinal pigment epithelial cells", Biomed Pharmacother, 85, pp.136~140 (2017)
- Zhong WF, "Eupatilin induces human renal cancer cell apoptosis via ROS-mediated MAPK and PI3K", AKT signaling pathways, 2016, pp.12, 2894~2899
- Lee S, "Eupatilin inhibits H(2)O(2)-induced apoptotic cell death through inhibition of mitogen-activated protein kinases and nuclear factor-kappaB", Food Chem Toxicol, 46, pp.2865~2870 (2008)
- Kim YW, "DA6034 promotes gastric epithelial cell migration and wound-healing through the mTOR pathway", J Gastroenterol Hepatol, 27, pp.397~405 (2012)
- Chung HJ, "Pharmacokinetics of DA-6034, an agent for inflammatory bowel disease, in rats and dogs: contribution of intestinal first-pass effect to low bioavailability in rats", Eur J Pharm Sci, 27, pp.363~374 (2006)
- Kim YS, "Effect of DA-6034, a derivative of flavonoid, on experimental animal models of inflammatory bowel disease", Arch Pharm Res, 22, pp.354~360 (1999)
- Jump DB, "Fatty acid regulation of hepatic gene transcription", J Nutr, 135, pp.2503~2506 (2005)
- Pettinelli P, "Molecular mechanisms of steatosis in nonalcoholic fatty liver disease", Nutr Hosp, 26, pp.441~450 (2011)
- Kuan YC, "Heat shock protein 90 modulates lipid homeostasis by regulating the stability and function of sterol regulatory element-binding protein(SREBP)and SREBP cleavage-activating protein", J Biol Chem, 292, pp.3016~3028 (2017)
- Ko SH, "A mechanism for the action of the compound DA-6034 on NF-κB pathway activation in Helicobacter pylori-infected gastric epithelial cells", Scand J Immunol, 74, pp.253~263 (2011)
- Stienstra R, "Specific and complex reprogramming of cellular metabolism in myeloid cells during innate immune responses", Cell Metab, 26, pp.142~156 (2017)
- Reilly SM, "Adapting to obesity with adipose tissue inflammation", Nat Rev Endocrinol, 13, pp.633~643 (2017)
- Weisberg SP, "Obesity is associated with macrophage accumulation in adipose tissue", J Clin Invest, 112, pp.1796~1808 (2003)
- Stienstra R, "Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity", Hepatology, 51, pp.511~522 (2010)
- Morgan PK, "Macrophage polarization state affects lipid composition and the channeling of exogenous fatty acids into endogenous lipid pools", J Biol Chem, 297, pp.101341~ (2021)
- Castoldi A, "Triacylglycerol synthesis enhances macrophage inflammatory function", Nat Commun, 11, pp.4107~ (2020)
- Manne V, "Pathophysiology of nonalcoholic fatty liver disease", nonalcoholic steatohepatitis, 2018, pp.22, 23~37
- Maeda S, "IKKbeta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFalpha", Immunity, 19, pp.725~737 (2003)
- Luedde T, "Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia", reperfusion injury, 2005, pp.115, 849~859
- Luedde T, "NF-κB in the liver: linking injury, fibrosis and hepatocellular carcinoma", Nat Rev Gastroenterol Hepatol, 8, pp.108~118 (2011)
- Stone MJ, "Mechanisms of regulation of the chemokine-receptor network", Int J Mol Sci, 18, pp.342~ (2017)
- Yang H, "CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis", Mol Cancer, 19, pp.41~ (2020)
- Parker R, "CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease", Am J Physiol Gastrointest Liver Physiol, 314, pp.G483~G493 (2018)
- Lee SJ, "CCR2 knockout ameliorates obesity-induced kidney injury through inhibiting oxidative stress and ER stress", PLoS One, 14, pp.e0222352~ (2019)
- Gutierrez DA, "Aberrant accumulation of undifferentiated myeloid cells in the adipose tissue of CCR2-deficient mice delays improvements in insulin sensitivity", Diabetes, 60, pp.2820~2829 (2011)
- Kitade H, "CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1", M2 status, 2012, pp.61, 1680~1690
- Huh JH, "Dual CCR2", 5 antagonist attenuates obesity-induced insulin resistance by regulating macrophage recruitment and M1, Obesity(Silver Spring), pp.2018, 26[DOI]
- Kim HM, "α-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2", PLoS One, 12, pp.e0179204~ (2017)
- Ambade A, "Pharmacological inhibition of CCR2", 5 signaling prevents and reverses alcohol-induced liver damage, steatosis, and inflammation in mice, 2019, pp.69, 1105~1121
- Tosello-Trampont AC, "Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production", J Biol Chem, 287, pp.40161~40172 (2012)
- Han R, "Effect of perfluorooctane sulphonate-induced Kupffer cell activation on hepatocyte proliferation through the NF-κB", TNF-α, Chemosphere, pp.2018, 200[DOI]
